Cargando…
Vaccine Effectiveness Against the SARS-CoV-2 B.1.1.529 Omicron Variant in Solid Organ and Islet Transplant Recipients in England: A National Retrospective Cohort Study
The effectiveness of vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.529 Omicron variant in immunosuppressed solid organ and islet transplant (SOT) recipients is unclear. METHODS. National registries in England were linked to identify SARS-CoV-2 positive tests...
Autores principales: | Callaghan, Chris J., Curtis, Rebecca M.K., Mumford, Lisa, Whitaker, Heather, Pettigrew, Gavin, Gardiner, Dale, Marson, Lorna, Thorburn, Douglas, White, Steven, Parmar, Jas, Ushiro-Lumb, Ines, Manas, Derek, Ravanan, Rommel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125014/ https://www.ncbi.nlm.nih.gov/pubmed/36727724 http://dx.doi.org/10.1097/TP.0000000000004535 |
Ejemplares similares
-
Real-world Effectiveness of the Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S Vaccines Against SARS-CoV-2 in Solid Organ and Islet Transplant Recipients
por: Callaghan, Chris J., et al.
Publicado: (2022) -
The rapid replacement of the Delta variant by Omicron (B.1.1.529) in England
por: Paton, Robert S., et al.
Publicado: (2022) -
Omicron (B.1.1.529): Infectivity, vaccine breakthrough, and antibody resistance
por: Chen, Jiahui, et al.
Publicado: (2021) -
Vaccination and Transmission Risk during the Outbreak of B.1.1.529 (Omicron)
por: Grüne, Barbara, et al.
Publicado: (2022) -
Identifying susceptibility of children and adolescents to the Omicron variant (B.1.1.529)
por: Chun, June Young, et al.
Publicado: (2022)